Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Tomasoni

Showing results (81-90 of 201) with videos related to

Pageof 21
Sort By:
ESC Heart Failure|December 5, 2020
Heart failure in the last year: progress and perspectiveDaniela Tomasoni, Marianna Adamo, Markus S Anker, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 28, 2022
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closureLuca Branca, Daniela Tomasoni, Giuliana Cimino, et al.
European Journal of Heart Failure|May 16, 2020
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new diseaseDaniela Tomasoni, Leonardo Italia, Marianna Adamo, et al.
ESC Heart Failure|December 17, 2021
A year in heart failure: an update of recent findingsLorenzo Stretti, Dauphine Zippo, Andrew J S Coats, et al.
Blood|May 8, 2010
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathwaySilvia Gregori, Daniela Tomasoni, Valentina Pacciani, et al.
Haematologica|February 10, 2015
HLA-G expression levels influence the tolerogenic activity of human DC-10Giada Amodio, Michela Comi, Daniela Tomasoni, et al.
ESC Heart Failure|March 30, 2022
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative careDaniela Tomasoni, Julie K K Vishram-Nielsen, Matteo Pagnesi, et al.
Heart Failure Reviews|July 4, 2026
Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forwardJoshua D Bennetts, Doan T M Ngo, Baljash Cheema, et al.
ESC Heart Failure|December 14, 2023
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonistsGiuliana Cimino, Muthiah Vaduganathan, Carlo M Lombardi, et al.
ESC Heart Failure|December 22, 2022
Heart failure: an update from the last years and a look at the near futureMauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
Pageof 21

Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
ESC Heart Failure|December 5, 2020
Heart failure in the last year: progress and perspectiveDaniela Tomasoni, Marianna Adamo, Markus S Anker, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 28, 2022
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closureLuca Branca, Daniela Tomasoni, Giuliana Cimino, et al.
European Journal of Heart Failure|May 16, 2020
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new diseaseDaniela Tomasoni, Leonardo Italia, Marianna Adamo, et al.
ESC Heart Failure|December 17, 2021
A year in heart failure: an update of recent findingsLorenzo Stretti, Dauphine Zippo, Andrew J S Coats, et al.
Blood|May 8, 2010
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathwaySilvia Gregori, Daniela Tomasoni, Valentina Pacciani, et al.
Haematologica|February 10, 2015
HLA-G expression levels influence the tolerogenic activity of human DC-10Giada Amodio, Michela Comi, Daniela Tomasoni, et al.
ESC Heart Failure|March 30, 2022
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative careDaniela Tomasoni, Julie K K Vishram-Nielsen, Matteo Pagnesi, et al.
Heart Failure Reviews|July 4, 2026
Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forwardJoshua D Bennetts, Doan T M Ngo, Baljash Cheema, et al.
ESC Heart Failure|December 14, 2023
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonistsGiuliana Cimino, Muthiah Vaduganathan, Carlo M Lombardi, et al.
ESC Heart Failure|December 22, 2022
Heart failure: an update from the last years and a look at the near futureMauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
Pageof 21